AGENUS INC (AGEN)
Biological Products, (No Diagnostic Substances)
Latest Price
$7.50
TTM P/E
3.66
Normalized P/E
--
Div Yield
--
Book Value
12.33
P/B Ratio
0.61
Institutional Ownership
22.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.44M | $4.0M | 3.74% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.20M | $3.0M | 3.10% | -- | 2026-03-31 |
| Siren, L.L.C. | 1.06M | $3.0M | 2.76% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 688.2K | $2.0M | 1.79% | +541.4K | 2026-03-31 |
| BlackRock, Inc. | 545.7K | $1.0M | 1.42% | -12.7K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 348.4K | $1.0M | 0.90% | -24.4K | 2026-03-31 |
| MORGAN STANLEY | 295.8K | -- | 0.77% | +10.6K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 285.6K | -- | 0.74% | -257.9K | 2026-03-31 |
| Man Group plc | 279.0K | -- | 0.72% | +164.8K | 2026-03-31 |
| RAYMOND JAMES FINANCIAL INC | 239.6K | -- | 0.62% | +97.9K | 2026-03-31 |